MedPath

An Observational Study of Disease Severity and Quality of Life in Japanese Patients with Ulcerative Colitis

Not Applicable
Conditions
lcerative Colitis
Registration Number
JPRN-UMIN000027750
Lead Sponsor
Takeda Pharmaceuticals Company Limited Japan Pharma Business Unit Healthcare Policy & Access
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

1.Individuals determined by the research supervisor or researcher to have potential comorbid conditions besides ulcerative colitis that may influence QoL. 2. Individuals participating in other interventional studies such as physician-investigator initiated clinical trials 3. The study investigator, any researcher member or aforementioned close relatives, as well as any reporting members of researchers (or their close relatives) 4. Individuals with prior registration for this study 5. Any individual the study investigator or researcher deems ineligible

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath